Cargando…

Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Hubert, Gervaise, Bittencourt, Henrique, Laverdière, Caroline, Teira, Pierre, Cellot, Sonia, Langlois, Sylvie, Rouette, Alexandre, Sontag, Thomas, Sinnett, Daniel, Dal-Soglio, Dorothée, Turpin, Sophie, Tran, Thai Hoa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230417/
https://www.ncbi.nlm.nih.gov/pubmed/36384252
http://dx.doi.org/10.3324/haematol.2022.281926
_version_ 1785051522676031488
author Hubert, Gervaise
Bittencourt, Henrique
Laverdière, Caroline
Teira, Pierre
Cellot, Sonia
Langlois, Sylvie
Rouette, Alexandre
Sontag, Thomas
Sinnett, Daniel
Dal-Soglio, Dorothée
Turpin, Sophie
Tran, Thai Hoa
author_facet Hubert, Gervaise
Bittencourt, Henrique
Laverdière, Caroline
Teira, Pierre
Cellot, Sonia
Langlois, Sylvie
Rouette, Alexandre
Sontag, Thomas
Sinnett, Daniel
Dal-Soglio, Dorothée
Turpin, Sophie
Tran, Thai Hoa
author_sort Hubert, Gervaise
collection PubMed
description
format Online
Article
Text
id pubmed-10230417
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-102304172023-06-01 Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia Hubert, Gervaise Bittencourt, Henrique Laverdière, Caroline Teira, Pierre Cellot, Sonia Langlois, Sylvie Rouette, Alexandre Sontag, Thomas Sinnett, Daniel Dal-Soglio, Dorothée Turpin, Sophie Tran, Thai Hoa Haematologica Case Report Fondazione Ferrata Storti 2022-11-17 /pmc/articles/PMC10230417/ /pubmed/36384252 http://dx.doi.org/10.3324/haematol.2022.281926 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Hubert, Gervaise
Bittencourt, Henrique
Laverdière, Caroline
Teira, Pierre
Cellot, Sonia
Langlois, Sylvie
Rouette, Alexandre
Sontag, Thomas
Sinnett, Daniel
Dal-Soglio, Dorothée
Turpin, Sophie
Tran, Thai Hoa
Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title_full Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title_fullStr Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title_full_unstemmed Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title_short Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
title_sort clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230417/
https://www.ncbi.nlm.nih.gov/pubmed/36384252
http://dx.doi.org/10.3324/haematol.2022.281926
work_keys_str_mv AT hubertgervaise clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT bittencourthenrique clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT laverdierecaroline clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT teirapierre clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT cellotsonia clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT langloissylvie clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT rouettealexandre clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT sontagthomas clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT sinnettdaniel clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT dalsogliodorothee clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT turpinsophie clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia
AT tranthaihoa clinicalresponsetodabrafenibandchemotherapyinclonallyrelatedhistiocytosisandacutelymphoblasticleukemia